ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease

Courtney Lane-Donovan, Joachim Herz

Research output: Contribution to journalReview articlepeer-review

85 Scopus citations


As the population ages, neurodegenerative diseases such as Alzheimer's disease (AD) are becoming a significant burden on patients, their families, and health-care systems. Neurodegenerative processes may start up to 15 years before outward signs and symptoms of AD, as evidenced by data from AD patients and mouse models. A major genetic risk factor for late-onset AD is the ɛ4 isoform of apolipoprotein E (ApoE4), which is present in almost 20% of the population. In this review we discuss the contribution of ApoE receptor signaling to the function of each component of the tripartite synapse – the axon terminal, the postsynaptic dendritic spine, and the astrocyte – and examine how these systems fail in the context of ApoE4 and AD.

Original languageEnglish (US)
Pages (from-to)273-284
Number of pages12
JournalTrends in Endocrinology and Metabolism
Issue number4
StatePublished - Apr 1 2017


  • LRP
  • NMDA receptor
  • Reelin.
  • calcium homeostasis
  • dendrite
  • endosome
  • synaptic dysfunction

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this